Renaissancere Holdings Ltd
NYSE:RNR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Renaissancere Holdings Ltd
NYSE:RNR
|
BM |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
US |
|
Japan Tobacco Inc
F:JAT
|
JP |
|
Lundin Gold Inc
TSX:LUG
|
CA |
|
T
|
Twist Bioscience Corp
F:0ME
|
US |
|
F
|
Fairfax Financial Holdings Ltd
OTC:FRFHF
|
CA |
|
A
|
Alibaba Group Holding Ltd
HKEX:9988
|
CN |
|
Darma Henwa Tbk PT
F:0DH
|
ID |
Wall St Price Targets
RNR Price Targets Summary
Renaissancere Holdings Ltd
According to Wall Street analysts, the average 1-year price target for RNR is 317.499 USD with a low forecast of 126.361 USD and a high forecast of 452.55 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RNR's stock price target?
Price Target
317.499
USD
According to Wall Street analysts, the average 1-year price target for RNR is 317.499 USD with a low forecast of 126.361 USD and a high forecast of 452.55 USD.
What is the Revenue forecast for Renaissancere Holdings Ltd?
Projected CAGR
-9%
Over the last 14 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is -9%.
What is the Net Income forecast for Renaissancere Holdings Ltd?
Projected CAGR
-9%
The compound annual growth rate for Net Income over the next 3 years is -9%.
